Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine Dosing and Timing in T2DM
NCT00349986Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Sep 2006
- Primary completion
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Sep 2006; status: terminated.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00349986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349986.